Lymphoma combo drug trial pulled before it even started
NCT ID NCT04607772
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to test the drug selinexor combined with other treatments for people with a type of blood cancer called diffuse large B-cell lymphoma that had come back or stopped responding to therapy. The trial was planned in two phases to first find the safest dose and then check how well it works. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-GRADE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Clinic - Mcnair Center
Houston, Texas, 77030, United States
-
California Cancer Associates for Research and Excellence
Encinitas, California, 92024, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48021, United States
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
Mission Cancer + Blood
Des Moines, Iowa, 50309, United States
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263, United States
-
UC San Diego Moores Cancer Center
La Jolla, California, 92093, United States
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
US Oncology - Northwest Cancer Specialists
Vancouver, Washington, 98684, United States
-
US Oncology - Oncology Associates of Oregon
Eugene, Oregon, 97401, United States
-
US Oncology - Prisma Health
Greenville, South Carolina, 29605, United States
-
US Oncology - Rocky Mountain Cancer Center
Aurora, Colorado, 80012, United States
-
US Oncology - Texas Oncology Austin Midtown
Austin, Texas, 78705, United States
-
University of Arizona
Tucson, Arizona, 85724, United States
-
University of California Irvine
Orange, California, 92868, United States
-
University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Texas Southwestern
Dallas, Texas, 75390, United States